Fear of Hypoglycemia in Adults with diabetes mellitus switching to Treatment with IDegAsp Co-formulation to Examine real-world setting: an observational study (The HATICE study)
Open Access
- 23 December 2020
- journal article
- research article
- Published by Walter de Gruyter GmbH in Drug Metabolism and Drug Interactions
- Vol. 36 (2) , 129-134
Abstract
Objectives: To evaluate the clinical results of insulin degludec/aspart (IDEgAsp) therapy and its effect on the fear of hypoglycemia. Methods: A prospective observational study has been conducted through surveys of 36 patients using insulin because of type 2 diabetes mellitus who initiated treatment with IDegAsp switching from other insulins. Patients, 18–75 years old, were recruited to the study, consecutively. Participants’ age, gender, height, weight, body mass index (BMI), daily insulin dose, glycated hemoglobin (HbA1c), hypoglycemia rate, hypoglycemia fear survey (HFS) were recorded at the beginning of the study. By the end of 12th month, data was re-measured and compared with each other. Results: HbA1c was declined by mean of −1.59% (95% CI −1.06 to −2.12, p1c, less injection administration, and decreased the fear of hypoglycemia in diabetics.Keywords
This publication has 22 references indexed in Scilit:
- Efficacy and safety of premixed insulin analogs in Asian patients with type 2 diabetes: A systematic reviewJournal of Diabetes Investigation, 2017
- Insulin degludec/insulin aspart versus biphasic insulin aspart 30 twice daily in insulin-experienced Japanese subjects with uncontrolled type 2 diabetes: Subgroup analysis of a Pan-Asian, treat-to-target Phase 3 TrialJournal of Diabetes, 2016
- Twice‐daily insulin degludec/insulin aspart provides superior fasting plasma glucose control and a reduced rate of hypoglycaemia compared with biphasic insulin aspart 30 in insulin‐naïve adults with Type 2 diabetesDiabetic Medicine, 2015
- Fear of hypoglycemia and its determinants in insulin‐treated patients with type 2 diabetes mellitusJournal of Diabetes Investigation, 2015
- The Impact of Nocturnal Hypoglycemia on Clinical and Cost-Related Issues in Patients With Type 1 and Type 2 DiabetesThe Diabetes Educator, 2014
- The role of FOXO1 in β-cell failure and type 2 diabetes mellitusNature Reviews Endocrinology, 2013
- Superior glycaemic control with once‐daily insulin degludec/insulin aspart versus insulin glargine in Japanese adults with type 2 diabetes inadequately controlled with oral drugs: a randomized, controlled phase 3 trialDiabetes, Obesity and Metabolism, 2013
- Analysis of Use of an Automated Bolus Calculator Reduces Fear of Hypoglycemia and Improves Confidence in Dosage Accuracy in Type 1 Diabetes Mellitus Patients Treated with Multiple Daily Insulin InjectionsJournal of Diabetes Science and Technology, 2012
- Hypoglycemia Fear and Self-efficacy of Turkish Patients Receiving Insulin TherapyAsian Nursing Research, 2011
- Fear of Hypoglycemia: Quantification, Validation, and UtilizationDiabetes Care, 1987